Literature DB >> 1377173

Genomic organization and chromosomal location of the human gene encoding the B-lymphocyte activation antigen B7.

A Selvakumar1, B K Mohanraj, R L Eddy, T B Shows, P C White, B Dupont.   

Abstract

The human B lymphocyte activation antigen B7 provides regulatory signals for T lymphocytes as a consequence of binding to its ligands CD28 and CTLA-4. The cDNA for B7 has previously been isolated and predicted to encode a type I membrane protein. The predicted polypeptide has a secretory signal peptide followed by two contiguous Ig-like domains, a hydrophobic transmembrane region and a short cytoplasmic tail. Here we report the exon-intron genomic organization of human B7 and the chromosomal location. The gene has six exons that span approximately 32 kilobases of DNA. Exon 1 is not translated and the second exon contains the initiation ATG codon and encodes a predicted signal peptide. This gene structure is characteristic for several eukaryotic genes with tissue-specific expression. The third and fourth exons correspond to two Ig-like domains whereas the fifth and sixth exons encode respectively the trans-membrane portion and the cytoplasmic tail. This close relationship between exons and functional domains is a characteristic feature of genes of the Ig superfamily. Cell surface expression of the B7 gene product has previously been mapped to human chromosome 12 by antibody reactivity with the B7-specific monoclonal antibody BB-1. We here demonstrate that the B7 gene is located to the q21-qter region of chromosome 3 by DNA blot analysis of human x rodent somatic cell hybrids.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1377173     DOI: 10.1007/bf00661094

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  25 in total

1.  CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location.

Authors:  K Harper; C Balzano; E Rouvier; M G Mattéi; M F Luciani; P Golstein
Journal:  J Immunol       Date:  1991-08-01       Impact factor: 5.422

2.  B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells.

Authors:  G J Freeman; A S Freedman; J M Segil; G Lee; J F Whitman; L M Nadler
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

3.  B7, a B-cell-restricted antigen that identifies preactivated B cells.

Authors:  A S Freedman; G Freeman; J C Horowitz; J Daley; L M Nadler
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

4.  T cell antigen receptors and the immunoglobulin supergene family.

Authors:  L Hood; M Kronenberg; T Hunkapiller
Journal:  Cell       Date:  1985-02       Impact factor: 41.582

5.  Human CD28 and CTLA-4 Ig superfamily genes are located on chromosome 2 at bands q33-q34.

Authors:  M Lafage-Pochitaloff; R Costello; D Couez; J Simonetti; P Mannoni; C Mawas; D Olive
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

6.  DNA sequence analysis with a modified bacteriophage T7 DNA polymerase.

Authors:  S Tabor; C C Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

7.  Interleukin 2 (IL2) is assigned to human chromosome 4.

Authors:  T Shows; R Eddy; L Haley; M Byers; M Henry; T Fujita; H Matsui; T Taniguchi
Journal:  Somat Cell Mol Genet       Date:  1984-05

8.  Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains.

Authors:  P Dariavach; M G Mattéi; P Golstein; M P Lefranc
Journal:  Eur J Immunol       Date:  1988-12       Impact factor: 5.532

9.  Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7.

Authors:  G J Freeman; G S Gray; C D Gimmi; D B Lombard; L J Zhou; M White; J D Fingeroth; J G Gribben; L M Nadler
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

10.  CTLA-4 is a second receptor for the B cell activation antigen B7.

Authors:  P S Linsley; W Brady; M Urnes; L S Grosmaire; N K Damle; J A Ledbetter
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

View more
  9 in total

1.  Genomic organization of the mouse B-lymphocyte activation antigen B7.

Authors:  A Selvakumar; P C White; B Dupont
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

2.  Genomic organization of the gene coding for the costimulatory human B-lymphocyte antigen B7-2 (CD86).

Authors:  C L Jellis; S S Wang; P Rennert; F Borriello; A H Sharpe; N R Green; G S Gray
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

3.  Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood monocytes.

Authors:  J Fleischer; E Soeth; N Reiling; E Grage-Griebenow; H D Flad; M Ernst
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

4.  Structural organization and mammary-specific expression of the butyrophilin gene.

Authors:  S L Ogg; M V Komaragiri; I H Mather
Journal:  Mamm Genome       Date:  1996-12       Impact factor: 2.957

5.  Evolution of the B7 family: co-evolution of B7H6 and NKp30, identification of a new B7 family member, B7H7, and of B7's historical relationship with the MHC.

Authors:  Martin F Flajnik; Tereza Tlapakova; Michael F Criscitiello; Vladimir Krylov; Yuko Ohta
Journal:  Immunogenetics       Date:  2012-04-11       Impact factor: 2.846

6.  Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation.

Authors:  V A Boussiotis; G J Freeman; J G Gribben; J Daley; G Gray; L M Nadler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

7.  Linkage of familial hemophagocytic lymphohistiocytosis to 10q21-22 and evidence for heterogeneity.

Authors:  R Dufourcq-Lagelouse; N Jabado; F Le Deist; J L Stéphan; G Souillet; M Bruin; E Vilmer; M Schneider; G Janka; A Fischer; G de Saint Basile
Journal:  Am J Hum Genet       Date:  1999-01       Impact factor: 11.025

8.  A cell type-specific enhancer in the human B7.1 gene regulated by NF-kappaB.

Authors:  J Zhao; G J Freeman; G S Gray; L M Nadler; L H Glimcher
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

9.  Harnessing NK cells for cancer immunotherapy: immune checkpoint receptors and chimeric antigen receptors.

Authors:  Nayoung Kim; Dong-Hee Lee; Woo Seon Choi; Eunbi Yi; HyoJeong Kim; Jung Min Kim; Hyung-Seung Jin; Hun Sik Kim
Journal:  BMB Rep       Date:  2021-01       Impact factor: 4.778

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.